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Abstract
Background: Home-based care is used in many countries to increase quality of life and limit hospital stay,
particularly where public health services are overburdened. Home-based care objectives for HIV/AIDS can include
medical care, delivery of antiretroviral treatment and psychosocial support. This review assesses the effects of
home-based nursing on morbidity in people infected with HIV/AIDS.
Methods: The trials studied are in HIV positive adults and children, regardless of sex or setting and all randomised
controlled. Home-based care provided by qualified nurses was compared with hospital or health-facility based
treatment. The following electronic databases were searched from January 1980 to March 2015: AIDSearch, CINAHL,
Cochrane Register of Controlled Trials, EMBASE, MEDLINE and PsycINFO/LIT, with an updated search in November
2016. Two authors independently screened titles and abstracts from the electronic search based on the study
design, interventions and types of participant. For all selected abstracts, full text articles were obtained. The final
study selection was determined with use of an eligibility form. Data extraction was performed independently from
assessment of risk of bias. The results were analysed by narrative synthesis, in order to be able to obtain relevant
effect measures plus 95% confidence intervals.
Results: Seven studies met the inclusion criteria. The trial size varied from 37 to 238 participants. Only one trial
was conducted in children. Five studies were conducted in the USA and two in China. Four studies looked at
home-based adherence support and the rest at providing home-based psychosocial support. Reported adherence
to antiretroviral drugs improved with nurse-led home-based care but did not affect viral load. Psychiatric nurse
support in those with existing mental health conditions improved mental health and depressive symptoms.
Home-based psychological support impacted on HIV stigma, worry and physical functioning and in certain cases
depressive symptoms.
Conclusions: Nurse-led home-based interventions could help adherence to antiretroviral therapy and improve
mental health. Further larger scale studies are needed, looking in more detail at improving medical care for HIV,
especially related to screening and management of opportunistic infections and co-morbidities.
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Background
HIV/AIDS is a significant cause of morbidity and mor-
tality in low and middle-income countries (LMICs),
where health services already contend with poor infra-
structure and limited resources including staff, drugs
and equipment. Approximately 36.7 million people are
living with HIV and around 52% of these are in Sub-
Saharan Africa [1]. In 2015, an estimated 2.1 million
people became newly infected with HIV/AIDS while 1.1
million of those with HIV/AIDS died [1].
The 2016 World Health Organisation (WHO) guide-
lines broaden the number of people eligible to start life-
saving antiretroviral therapy (ART) [2]. Although these
changes can improve clinical outcomes and reduce the
incidence of HIV, they pose a challenge for public health
services already overburdened with limited human and
financial resources. Global coverage of antiretroviral
therapy increased to 46% at the end of 2015 but dispar-
ities remain between high and low income countries [1].
* Correspondence: elizabethwood3@nhs.net
1Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wood et al. BMC Health Services Research  (2018) 18:219 
https://doi.org/10.1186/s12913-018-3002-4
Barriers to accessing and retaining care include
amongst others transport costs, long waiting times and a
shortage of healthcare staff [3]. Decentralising HIV treat-
ment to community or home based settings and task-
shifting using non-physician health workers for the
initiation and maintenance of ART may help to over-
come some of these problems, and these measures are
being adopted as key management strategies [4–6].
Home-based care
The WHO defines home-based care (HBC) as any form
of care given to ill people in their homes, including
physical, psychosocial, palliative and spiritual activities
[7]. There are various types of HBC including integrated
HBC where all service providers are involved, single ser-
vice HBC involving one organisation, and informal HBC
with no formal support structure [8]. HBC can be car-
ried out by a variety of people including qualified health-
care practitioners, nurses, trained lay community health
workers, peer health workers and HBC volunteers [9].
Providing care in the home can overcome some of the
barriers to care, such as transport costs and waiting times,
and help to reduce the burden on health facilities [10].
Other benefits of HBC include lower costs at both individ-
ual and country level, personalised care and being in famil-
iar surroundings. It can also reduce demand on hospital
beds and increase effective time use in hospitals [10].
Home-based care for HIV
HBC has been defined by the Committee on a Na-
tional Strategy for AIDS (CNSA) for the USA as care
at the patient’s residence to supplement or replace
hospital care including medical management, palliative
care and social support [8]. HBC objectives for HIV/
AIDS can include improved medical care, delivery of
ART and improved psychosocial well-being (Fig. 1
Home-based care as a management strategy for
people with HIV). It could have positive social out-
comes by helping to reduce the stigma surrounding
HIV, thereby improving support, access and adherence
to ART and uptake of testing [10, 11]. An integrated
approach using HBC to provide co-ordinated care for
a number of conditions has been suggested, for in-
stance combining HIV and tuberculosis management
[12, 13].
Recent expansion of ART programmes has led to a
growing emphasis on the decentralisation of HIV treat-
ment in LMICs. Kredo assessed the effects of decentra-
lised HIV care in relation to both initiation and
maintenance of ART [5]. Wringe reviewed whether the
conditions are in place to effectively scale up HBC pro-
grammes for increased ART, in terms of available human
resources, health systems and funding mechanisms.
They concluded that sustainable funding needs to be en-
sured, and policies to encourage staff retention and ser-
vice integration are needed [10].
Fig. 1 Home-based care as a management strategy for people with HIV
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Home-based care for other conditions
A number of reviews have examined the effects of home
care for a variety of conditions. Okwundu found that
home or community-based programmes for treating
malaria could increase the number of people who
receive appropriate anti-malarial treatment and may re-
duce all-cause mortality [14]. For cardiovascular disease,
Clark found that home-based secondary prevention pro-
grammes conducted by health professionals are as
effective as hospital based cardiac rehabilitation, and
considerably lower in cost [15]. A study looking at end
of life care at home for terminal patients supported the
use of home care programmes for increasing the num-
bers of patients who will die at home [16]. In contrast,
Smeenk concluded that the effectiveness of home care
programmes for patients with terminal cancer remains
unclear [17].
Task-shifting
Task shifting from medical doctors to nurses is a poten-
tially effective strategy to overcome the medical work-
force shortage and to address the needs associated with
chronic HIV/AIDS [13]. The increasing use of lay health
workers to fill gaps in the work force raises the issues of
training required and the quality of care provided. A re-
view examining the use of lay health workers in the
management of infectious diseases found them to be ef-
fective for improving tuberculosis outcomes but there
was insufficient evidence to make a conclusion regarding
adherence support in HIV/AIDS [18].
Kredo found that there is probably no reduction in the
quality of care when trained nurses or community health
workers initiate and maintain ART. When nurses initiate
and maintain ART, there may also be lower loss to
follow-up compared with doctors [6]. More research is
needed into the level of training required and the ability
of these workers to perform effectively whilst taking on
multiple roles [9, 19].
Why is it important to do this review?
In addition to the delivery of ART, other current key is-
sues in the multidimensional care of HIV/AIDS include
counselling and home-based testing, pre-ART care (such
as repeating eligibility assessment), delivery of preventa-
tive interventions, distribution of prophylaxis, treatment
of opportunistic infections and supportive psychosocial
activities.
Young found a range of HBC models and interven-
tions for HIV but these were generally from small stud-
ies and the majority were based in developed countries
[20]. Since this review was published, there has been a
change in the evidence with more focus on HBC in
LMICs. Home-based HIV voluntary counselling and
testing has been found to have the potential to increase
uptake in developing countries [21]. Nurses are an im-
portant element of HBC for HIV but have not been cov-
ered in depth in Young or any other recent review. This
review assesses the effects of home-based nursing to re-
duce morbidity in people infected with HIV/AIDS.
Methods
Criteria for considering studies for this review
We included all randomised controlled trials (RCTs)
conducted amongst HIV/AIDS positive individuals,
adults and children, comparing home-based care, includ-
ing all forms of treatment, care and support offered in
the HIV/AIDS positive person’s home by qualified
nurses who have received a formal professional certifi-
cate or tertiary education degree, compared to hospital
or health-facility based treatment. Home-based HIV vol-
untary counselling and testing was excluded as it is cov-
ered in Bateganya [21]. Initiation and delivery of ART
was excluded as it is covered in Kredo [5]. We consid-
ered various outcomes including progression to AIDS,
death, psychosocial outcomes (mood scores, stigma, pa-
tient and carer preferences), quality of care, quality of
life, inpatient days, and number and type of opportunis-
tic infections.
Search methods for identification of studies
The following electronic databases were searched from
1980 to March 2015: Cochrane Register of Controlled
Trials, MEDLINE, EMBASE, AIDSearch, CINAHL,
PsycINFO/LIT, with an updated search in MEDLINE in
November 2016. Detailed search strategies were com-
piled for each database searched (Table 1 details the
MEDLINE search strategy). Clinicaltrials.gov and the
WHO International Clinical Trials Registry Platform
were searched in March 2015 to identify on-going trials.
The strategy was iterative, in that references of included
studies were searched for additional references. All lan-
guages were included.
Selection of studies, data collection and analysis
Titles, abstracts and descriptor terms of the electronic
search results were screened independently by two au-
thors for relevance based on predefined eligibility cri-
teria. Full text articles were obtained of all selected
abstracts and final eligibility assessed. Data including ad-
ministrative details, study design, details of the interven-
tion and control, and outcomes were extracted
independently by two authors using a standardised data
extraction form.
The risk of bias of included studies was also evaluated
independently by two authors using the Cochrane risk of
bias tool. We assessed and summarised the following
main items in the ‘Risk of Bias’ table: sequence gener-
ation, allocation concealment, blinding of participant
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and personnel, blinding of outcome assessment, whether
incomplete outcome data were adequately addressed, se-
lective reporting and any other bias.
Missing or inadequate data were addressed by contact-
ing authors. We resolved disagreements by discussion.
Relevant effect measures and the 95% confidence in-
tervals (CI) were reported. We planned to assess sources
of clinical and methodological heterogeneity by looking
at characteristics of studies, evaluating similarity be-
tween type of participants, intervention used and out-
comes. However, due to the varied outcomes used in the
included studies no meta-analysis could be conducted.
Results
Description of studies
Seven studies met the inclusion criteria (Fig. 2 Flow dia-
gram of study selection). In addition, we identified one
on-going trial currently being conducted in Kenya inves-
tigating home-based directly observed ART [22]. Fifty
studies were excluded. Reasons for exclusion are detailed
in Table 2.
Individuals were randomised in each of these seven
studies. Trial sizes varied from n = 37 to n = 238. Only
one trial was conducted in children [23] whilst the rest
were conducted in adults (≥18 years). One trial focused
on female adults [24] and the others included males
and females. Five studies were conducted in the USA
[23–27] and two in China [28, 29].
The interventions studied and outcomes measured var-
ied between studies (Table 3). Four studies could be classi-
fied under home-based adherence support [23, 27–29].
Five studies investigated providing home-based psycho-
social support [24–26, 28, 29].
Detailed information on the participants, interven-
tions, controls and outcomes can be found in Table 3.
Risk of bias in included studies
The risk of bias assessment is summarised in Table 4.
Table 1 MEDLINE search strategy
Search Most recent queries
#1 Search HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human
immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human 19rospe-deficiency virus[tw] OR human immune-deficiency
virus[tw] OR ((human 19rospe*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency
syndrome[tw] OR acquired 19rospe-deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired 19rospe*) AND
(deficiency syndrome[tw])) OR “Sexually Transmitted Diseases, Viral”[MeSH:NoExp]
#2 Search randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR
double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (“clinical trial” [tw]) OR ((singl* [tw] OR
doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research
design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh]
OR control* [tw] OR 19rospective* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh])
#3 Search Home-based care or homebased care or home based care
#4 Search Home care or homecare or home-care
#5 Search Home
#6 Search #3 OR #4 OR #5
#7 Search #1 AND #2 AND #6
Fig. 2 Flow diagram of study selection
Table 2 Table of excluded studies
Reason for exclusion Number of studies [references]
Not all participants are HIV positive 3 studies [34–36]
Intervention studied was not
home-based care
5 studies [37–41]
Intervention was not provided
by qualified nurses
15 studies [42–56]
Comparison of two models of
home-based care
2 studies [57, 58]
Study investigating home-based
voluntary HIV counselling and testing
12 studies [59–70]
Not a randomised controlled trial 12 studies [71–82]
Trial terminated for non-compliance
with human subject regulations
1 study [83]
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Allocation (selection bias)
All trials stated that participants were randomised. Five
trials used adequate methods for generating the alloca-
tion sequence. Of these five trials, two used random
number tables [23, 24], one used a computer generated
algorithm [26] and two used a stratified randomisation
procedure [27, 29]. Allocation concealment was ad-
equate in two trials [23, 26] and not reported in the
remaining trials.
Blinding (performance bias and detection bias)
In Williams 2006 all personnel (except the home
intervention team) and the interviewers were blind
throughout the course of the study whereas in
Hanrahan and Miles, only the data collectors were
blinded [24, 26, 27]. Blank was designed to be single
blind for the research staff but participants sometimes
disclosed information, which made it possible to iden-
tify their experimental status [25].
In Williams 2014 there was no blinding of the partici-
pants but it was unclear whether the outcome assessors
were blinded [29]. Berrien used no blinding and Wang
did not report blinding [23, 28].
Incomplete outcome data (attrition bias)
Three trials reported a loss to follow up of less than 20%
and two reported a loss to follow up of less than 30%
[23, 26, 28]. Miles had a high loss to follow up of 51% in
the intervention group and 58% in the control group
[24]. One study did not report loss to follow up [25].
Selective reporting (reporting bias)
All outcomes stated were reported.
Effects of interventions
The effects of the various interventions are summarised
in Table 5.
Adherence support
Four studies, one in children [23] and three in adults
[27–29] examined the effects of an intensive home
based nursing programme compared to standard care
on adherence to ART. Berrien, Williams 2006 and
Williams 2014 also reported viral load and CD4 counts
[23, 27, 29]. However, due to differences in the way
these three outcomes were measured and reported we
could not do a meta-analysis.
Table 3 Description of included studies
Category Type of intervention
and comparison
Study ID Participants Follow-up
duration
Study
location
Outcomes
Adherence
support
Home-based
nursing vs.
standard care
Berrien
2004 [23]
HIV-positive children. N = 37. 12 months. Connecticut,
USA.
Adherence;
Viral load; CD4 count.
Wang
2010 [28]
HIV-positive adults; active or previous heroin
addicts; on ART at least 1 month prior to
starting study. N = 116.
10 months. Hunan,
China.
Adherence.
Williams
2006 [27]
HIV-positive adults on ART. N = 171. 15 months. Connecticut,
USA.
Adherence;
Viral load; CD4 count.
Williams
2014 [29]
HIV-positive adults; on ART; self-reported
< 90% adherence to pre-ART medications
or to ART; willing to receive home visits.
N = 110.
12 months. Hunan,
China.
Adherence;
Viral load; CD4 count.
Improved
psycho-social
wellbeing
Home based
nursing vs.
standard care
Blank
2014 [25]
HIV-positive adults; understand spoken
English; had a diagnosed serious mental
illness; able to provide informed consent.
N = 238.
24 months. Philadelphia,
USA.
Health related quality
of life; Viral load;
CD4 count.
Hanrahan
2011 [26]
HIV-positive adults; lived within the city
limits of Philadelphia; had a diagnosed
serious mental illness (SMI). N = 238.
12 months. Philadelphia,
USA.
Psychiatric symptoms;
Health related quality
of life
Miles
2003 [24]
African American women with HIV who
were primary caregivers for at least one
child under the age of 9 years. N = 109.
6 months. USA. Emotional distress
(depression, stigma,
worry); Health related
quality of life
Wang
2010 [28]
HIV-positive adults; active or previous
heroin addicts; on ART at least 1 month
prior to starting study. N = 116.
10 months. Hunan,
China.
Quality of life,
Depression
Williams
2014 [29]
HIV-positive adults; on ART; self-reported
< 90% adherence to pre-ART medications
or to ART; willing to receive home visits. N = 110.
12 months. Hunan,
China.
Depressive symptoms;
social support; HIV
stigma scale.
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Table 4 Risk of bias of included studies
Bias Berrien 2004 [23] Blank 2014 [25] Hanrahan 2011 [26] Miles 2003 [24] Wang 2010 [28] Williams 2006 [27] Wiliams 2014 [29]
Random
sequence
generation
Small table of
random digits.
Randomised on
a 1:1 basis but
method unclear.
Computer-
generated
algorithm
Table of
random
numbers.
Not reported. Stratified
randomisation,
with block size
of 10.
Stratified
randomisation,
with block size
of 10.
Allocation
concealment
Randomisation list
held by clinical
coordinator of HIV
program, kept in a
locked file.
Not reported. Person allocating
different from the
one assessing the
inclusion.
Not reported. Not reported. Not reported. Not reported.
Incomplete
outcome
data
Lost to follow-up:
5% intervention;
11% control.
Lost to follow up
not reported.
Lost to follow-up:
10% intervention;
5% control.
Lost to
follow-up at
6 months: 51%
intervention;
58% control.
Lost to
follow-up: 14%
intervention;
17% control.
Lost to follow-up
at 12 months:
28% intervention;
25% control.
Lost to follow-up
at 12 months: 5%
intervention; 22%
control.
Selective
reporting
All outcomes
reported.
All outcomes
reported.
All outcomes
reported.
All outcomes
reported.
All outcomes
reported.
All outcomes
reported.
Incomplete
reporting of
social support
and stigma.
Blinding of
participants
and
personnel
None. Participants
not blinded.
None. None. Not reported. All personnel
were blinded
except the home
visit team.
Participants
not blinded.
None.
Blinding of
outcome
assessment
None. Research staff
blinded.
Participants
disclosed
information,
unmasking
experimental
status.
Data collectors
blinded.
Data collectors
blinded.
Not reported. All personnel
including
interviewers were
blinded except
the home visit
team.
Not reported.
Table 5 Summary of results
Outcomes Summary
Adherence
support
Adherence -Self-reported adherence improved with intervention [23, 28, 29].
-Intervention increased ratio of the number of recorded Medication Event Monitoring Systems
(MEMS) cap openings to the number of openings to be expected if the medication
were taken as prescribed [27].
-Pharmacy drug refill increased significantly with intervention [23].
Viral load No significant change [23, 27, 29].
CD4 count No significant change [23, 27, 29].
Improved
psycho-social
wellbeing
Health-related
quality of life
-SF-12 mental health subscale improved with intervention but not the SF-12 physical
health subscale [25].
-No clear difference in health related quality of life outcomes (SF-12) [26].
-Improved WHO quality of life measures [28].
Psychiatric symptoms No significant difference between groups in reduction in psychiatric symptoms
(Colorado Symptom Index (CSI) score) [26].
Emotional distress
(depression, stigma, worry)
-Reduced symptoms of depression (PHQ-9 score) with intervention [26].
-Reduced HIV stigma, worry, physical functioning but no significant
difference in depressive symptoms, mood, general health or overall functioning [24].
-Reduced symptoms of depression (Self-rating Depression Scale) [28].
-Reduced symptoms of depression (CESD scale) in intervention group.
No significant difference in social support (SSRS) and stigma (HIV stigma scale) [29].
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In Berrien’s study (n = 37) a home care registered
nurse made eight pre-planned home visits over three
months, aiming to increase patient understanding of
HIV infection and ARVs and prevent issues with adher-
ence [23]. Standard care in a clinic included the doctor,
nurse, and social worker providing customary medica-
tion adherence education. Medication adherence mea-
sured by pharmacy drug refill was significantly better
(mean refill score 2.7 in the intervention group and 1.7
in control group, p = 0.002). The intervention group also
showed improvement in their knowledge score com-
pared to the control group (p = 0.02) and in their re-
ported adherence although this difference was not
statistically significant (p = 0.07).
There were no significant differences in the change
in CD4 counts or viral loads either immediately or
6–11 months later. 45% of participants in the
intervention group maintained or achieved a viral
load, < 2.6 log10copies/ml (<400copies/ml) compared
to 24% in the control group. CD4 figures were not
reported [23]. This study had a low risk of selection
and attrition bias but the small sample size of the
study reduces the quality of these results.
Wang (n = 116) provided nurse-delivered home visits
combined with telephone calls to HIV-infected heroin
users to the intervention group, whilst the control group
received routine care involving a monthly clinic visit
[28]. Assessment of selection, performance and detection
bias was not possible due to lack of reporting of these
methodological aspects. There was a low risk of attrition
bias and at the end of the eight months, participants in
the experimental group were more likely to report taking
100% of pills (Mantel-Haensel 1.57, 95% CI 1.19 to 2.07,
reported p = 0.0001) and taking pills on time (Mantel-
Haensel 2.50, 95% CI 1.51 to 4.13, reported p = 0.0001)
than those in the control group.
Williams 2006 (n = 171) assessed an adherence tool
which followed a structured educational model facili-
tated by a nurse and community support worker con-
ducting home visits, compared to standard care [27].
Adherence was recorded as the ratio of the number of
Medication Event Monitoring Systems cap (MEMS cap)
openings to number of openings expected if the medica-
tion was taken as prescribed. There was a low risk of
detection bias, loss to follow-up of 28% and 25% respect-
ively, and allocation concealment was not reported. The
median CD4 counts were 345 and 341 for the interven-
tion and control arms respectively. Comparing the
proportion of participants with greater than 90% adher-
ence, there was a statistically significant difference be-
tween the two arms at 15 months, favouring the
intervention group (reported extended Mantel-Hansel
test 5.80, p = 0.02). There were no significant changes at
12 and 15 months in proportion of people with CD4
count greater than 200 or undetectable viral loads
(actual figures not reported).
Williams 2014 (n = 110) investigated the effects of an
adherence intervention, which included home-based so-
cial and educational components provided by a nurse
and peer educator, compared to standard care adherence
clinic support services [29]. A visual analogue scale was
used to evaluate adherence to ART over the previous
30 days. There is a risk of attrition bias with differential
loss to follow-up of 5% and 22% at 12 months. At base-
line all subjects reported taking 90% or less of prescribed
medication (pre-ART or ART). In reported bivariate
analyses, there was a significant difference in adherence
between the two groups at 6 and 12 months (p = 0.003
and p = 0.005). In reported multivariate analyses, con-
trolling for baseline factors, the experimental group had
a significantly higher proportion of people who were ad-
herent (p = 0.009). The proportion of those with an un-
detectable viral load increased in both groups at
6 months (44% in control group, 57% in intervention
group) and at 12 months (59% control group, 72% inter-
vention group). But in multivariate analyses controlling
for baseline factors, there was no difference between
groups (p = 0.18). In reported multivariate analyses CD4
count did not differ by group (p = 0.65) but an overall in-
crease in CD4 count category was seen in all subjects
between baseline and 12 months (p = 0.003).
Psychosocial support
Five studies investigated the effects of a home-based
programme provided by nurses on psychological well-
being [24–26, 28, 29].
Psychiatric care
Blank (n = 238) examined a home-based advanced prac-
tice psychiatric nurse intervention in individuals with
serious mental illness and HIV [25]. The nurse provided
in-home consultations and co-ordinated medical and
mental health services. Growth curve analysis estimating
the treatment effects on viral load (log10copies/ml) and
Medical Outcomes Study 12-Item Short-Form Health
Survey (SF-12) mental health scores, showed that the
intervention reduced the rate of change over time in
viral load and increased the rate of change over time in
SF-12 mental health outcomes. They also compared
CD4 percentage and the SF-12 mental health score,
showing only significant treatment effect for SF-12 men-
tal health score. A model comparing viral load and SF-
12 physical health scores showed a significant decline in
viral load but no change in perceptions of physical
health status. A model comparing CD4 and SF12 phys-
ical health showed no significant change. Therefore, re-
sults show significant improvement in health-related
quality of life for a mental health subscale but not for a
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physical health subscale. However, there was a risk of
both detection and performance bias.
Hanrahan (n = 238) evaluated a home-based advanced
practice psychiatric nurse intervention in individuals
with serious mental illness and HIV [26]. The nurse pro-
vided in-home consultations and co-ordinated medical
and mental health services. Both groups had a reduction
in psychiatric symptoms (Colorado Symptom Index
(CSI) score) from baseline to 12 months, but the rela-
tive difference in these improvements was not signifi-
cant (reported effect (d) = − 4.03, 95% CI -15.99 to
7.83, p = 0.51). However, during the same period
symptoms of depression (PHQ-9 score) significantly
decreased in the experimental group compared to the
control group, with an average treatment effect of an
increased PHQ-9 score of 4.40 (95% CI -2.66 to
11.46, p = 0.2). There was no clear difference in
changes in health-related quality of life outcomes (SF-12)
over time between groups. In repeated measured random
regression models, Group x Time interactions were all
non-significant (reported p > 0.05). Allocation conceal-
ment was adequate and data collectors were blinded.
Counselling and emotional support
Miles (n = 109) assessed the psychosocial impact of home
visits carried out by three registered nurses in the homes
of African American women with HIV who were the prin-
cipal caregivers for one or more children under the age of
nine [24]. At six months, there was a statistically signifi-
cant difference in scores for physical functioning (Medical
Outcomes Survey-HIV (MOS-HIV)) (WMD 1.45, 95% CI
0.01 to 2.89), HIV stigma (Demo HIV stigma scale)
(WMD -0.25, 95% CI -0.49 to − 0.01) and HIV worry
(HIV worry scale) (WMD -0.46, 95% CI -0.89 to − 0.03).
For depressive symptoms (Centre for Epidemiological
Studies Depression (CESD) scale), mood (Profile of Mood
States (POMS)), general health, and overall functioning
(MOS-HIV), no statistically significant difference was
found. This study however had a high loss to follow up
which weakens the quality of results.
Wang (n = 116) examined the effects of nurse-
delivered home visits combined with telephone calls on
the quality of life of HIV-infected heroin users [28]. The
intervention had a significant effect in reducing the
symptoms of depression (assessed using Chinese version
of Self-rating Depression Scale (SDS)) (MD -11.53, 95%
CI -17.74 to − 5.92). Quality of life measures (measured
by the Chinese version of WHO Quality of Life) also im-
proved including physical (MD 2.97, 95% CI 1.75 to
4.19), psychological (MD 2.72, 95% CI 1.61 to 3.83), so-
cial (MD 2.10, 95% CI 0.78 to 3.42) and environmental
(MD 2.40, 95% CI 1.23 to 3.57) domains.
Williams 2014 (n = 110) investigated the effects of
nurse-delivered home visits on symptoms of depression
(CESD scale), social support (Social Support Rating Scale
(SSRS)) and stigma (HIV stigma scale) [29]. At baseline,
reported multivariate analyses adjusting for baseline so-
cial support, stigma and raw CESD score, showed a sig-
nificant difference in overall depression scores between
the two groups (p = 0.001), with the control group hav-
ing a higher percentage of people with CESD score ≥ 16.
When baseline CESD scores were compared to 12-
month CESD scores, they reported a significant decrease
in depressive symptoms in the intervention group com-
pared to the control group (p = 0.03). There was also a
significant change between the six-month CESD scores
and 12-month CESD scores, with an increase in depres-
sive symptoms in control subjects and decrease in inter-
vention subjects (p = 0.05). Baseline raw CESD and
baseline stigma were significant predictors of CESD
scores (p < 0.001 and p = 0.003 respectively) but not
baseline social support.
Discussion
Over the past five years various reviews have assessed
community-based care for HIV (Table 6). Interventions
have looked at decentralised treatment and use of lay
health workers and volunteers. The WHO recommends
that nurse-led teams can deliver most interventions
including initiating and monitoring ART, managing
uncomplicated opportunistic infections and providing
primary mental health and neurological care [30]. Our
review adds to what is known by focussing on assessing
the effects of home-based nursing on morbidity in
people with HIV/AIDS.
To minimise publication and indexing bias, we used
two authors working independently to select studies,
perform data extraction and risk of bias assessments.
The review included seven studies, conducted in the
USA and China. Included studies were small, conducted
mainly in adults. Five trials used adequate methods for
generating the allocation sequence [23, 24, 26, 27, 29]
and allocation concealment was adequate in two trials
[23, 26]. Only one trial reported high losses to follow up
[24]. This type of intervention is difficult to blind and
only one trial blinded personnel and data collectors [27].
Another limitation is that grey literature was not
searched.
Reported adherence to ART improved with nurse-led
home-based care. Self-reported adherence measures
could be liable to a social desirability bias in which par-
ticipants felt obliged to report that their adherence was
better at the end of the trial because they were aware
that this is what the intervention is aiming to achieve.
However more objective measures to adherence such as
the pharmacy drug refill did also support this. Despite
improved adherence to ART, the interventions did not
appear to affect biological parameters. Interestingly a
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review of direct observation in HIV therapy, mostly per-
formed in the community, also reported no effect on
virological suppression [31]. Possible reasons for a high
viral load despite adherence include drug resistance,
treatment failure or an adequate adherence irrespective
of the intervention [31]. Another systematic review
examining interventions for enhancing adherence to
ART also concluded that nurse-led home-based strat-
egies are effective [32].
In terms of psychological support, psychiatric nurse
home interventions improved depressive symptoms in
those with an existing mental health condition. Other
findings for home based psychological support were
mixed. Two studies found a reduction in symptoms of
depression, whilst another found no difference, but
stigma scales and physical functioning were improved.
This highlights the potential psychosocial benefits of
home-based care but with the self-reported scales, there
could also be an element of the social desirability bias
mentioned above, particularly as participants were not
blinded. Wouters 2012 also found that community-
based initiatives providing social support and counselling
to people living with HIV could effectively support and
improve medical care [9].
None of the included studies looked at improved med-
ical care (Fig. 1). With the current move to test and
treat, pre-ART care is now not so relevant but other
medical care such as screening for opportunistic infec-
tions and co-morbidities and related referral is import-
ant. Oni et al. found a high prevalence of multiple
morbidities among ART patients aged under 45 years
[33]. With the increase in diseases of lifestyle, such as
diabetes and hypertension, early identification and man-
agement of co-morbidities is also important [33].
Conclusions
The results indicate that nurse led home-based interven-
tions could help adherence to ART. Psychiatric nurse
support in those with existing mental health conditions
improved mental health and depressive symptoms.
Home-based psychological support impacted on HIV
stigma, worry and physical functioning and in certain
cases depressive symptoms.
However, studies were generally small and conducted
in limited geographic areas, limiting the quality of evi-
dence. Further larger scale studies are needed looking in
more detail at improving home-based medical care for
HIV, for example screening for opportunistic infections
and co-morbidities.
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